We are live on ! Find out more
BTX.WS

BioTime Inc Warrants (Expiring October 1, 2018)

Delisted

BTX.WS was delisted on the 26th of September, 2018.

35 hedge funds and large institutions have $1.04M invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more funds holding

Funds holding: 3535 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

21% less capital invested

Capital invested by funds: $1.31M → $1.04M (-$270K)

Holders
35
Holders Change
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
4
Closed
2
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change

BTX.WS Hedge Fund Activity: Q4 2016 in Review

35 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q4 2016, worth a combined $1.04M — down 21% from $1.31M a quarter earlier.

Fund positioning in BTX.WS was balanced in Q4 2016: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 4 trimmed.

The largest buyer was Ionic Capital Management, adding an estimated $7.63K. The largest seller was Fidelity Investments, cutting an estimated $66.7K.

  • 35 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $1.04M of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q4 2016, down 21% quarter-over-quarter.
  • 2 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q4 2016 and 2 closed out, a net change of 0 holders.
  • The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q4 2016 was Ionic Capital Management, an estimated $7.63K added.
  • The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q4 2016 was Fidelity Investments, an estimated $66.7K sold.

Based on aggregated 13F filings for Q4 2016.